%0 Journal Article
%T Updating the landscape of direct-to-consumer pharmacogenomic testing
%A John D Murphy
%A Kathy J Helzlsouer
%A Kelly K Filipski
%J Archive of "Pharmacogenomics and Personalized Medicine".
%D 2017
%R 10.2147/PGPM.S140461
%X Pharmacogenomics has identified important drug¨Cgene interactions that affect the safety and efficacy of medications. Direct-to-consumer genetic testing, when first introduced, included some pharmacogenomic-related genes. The current landscape of pharmacogenomic direct-to-consumer testing is reviewed. Prior published reviews of the literature were updated through February 2017 and a scan of the current availability of direct-to-consumer genomic testing by companies was conducted. Results of the review demonstrate a shift toward physician-approved ordering
%K pharmacogenomics
%K direct-to-consumer testing
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572950/